Gabexate mesilate is a synthetic protease inhibitor that is effective for acute pancreatitis. The effect of gabexate mesilate in influenza pneumonia in mice was investigated by examining the changes in pulmonary inflammatory cytokines and chemokines. Pathological changes in the lungs of treated mice were extremely mild, compared with changes in infected, untreated mice. Intrapulmonary levels of interleukin-6 and macrophage inflammatory protein-2 decreased in treated mice compared with untreated mice, despite similar viral titres in the lungs. Survival terms for treated and untreated groups were similar. These data indicate that gabexate mesilate has beneficial effects on influenza pneumonia, which may be due to the modulation of inflammatory cytokine/chemokine responses.
GlezenWPGreenbergSAtmarRL: Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA2000; 283: 499–505.
3.
PotterCW: Influenza. In: Principles and Practice of Clinical Virology (ZuckermanAJBanatvalaJPattisonJR, eds), 5th edn.Chichester: John Wiley, 2004, pp 271–297.
4.
MandellLAWunderinkRGAnzuetoA: Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis2007; 44: S27–S72.
5.
WoodheadMBlasiFEwigS: Guidelines for the management of adult lower respiratory tract infections. Eur Respir J2005; 26: 1138–1180.
6.
KidoHOkumuraYYamadaH: Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents. Curr Pharm Des2007; 13: 403–412.
7.
KidoHYokogoshiYSakaiK: Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein. J Biol Chem1992; 267: 13573–13579.
8.
TashiroMYokogoshiYTobitaK: Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity. J Virol1992; 66: 7211–7216.
9.
WhiteMRCrouchEVesonaJ: Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am J Physiol Lung Cell Mol Physiol2005; 289: L606–L616.
10.
WhiteMRCrouchEvan EijkM: Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. Am J Physiol Lung Cell Mol Physiol2005; 288: L831–L840.
11.
SekiMYanagiharaKHigashiyamaY: Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J2004; 24: 143–149.
12.
SekiMHigashiyamaYTomonoK: Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa. Clin Exp Immunol2004; 137: 35–40.
13.
TakahashiHFunahashiHSawaiH: Synthetic serine protease inhibitor, gabexate mesilate, prevents nuclear factor-κB activation and increases TNF-α-mediated apoptosis in human pancreatic cancer cells. Dig Dis Sci2007; 52: 2646–2652.
14.
InoueSSugitaniAYamamotoH: Effect of synthetic protease inhibitor gabexate mesilate on the attenuation of ischemia/reperfusion injury in canine kidney autotransplantation. Surgery2005; 137: 216–224.
15.
HaradaHMiyakeHOchiK: Clinical trial with a protease inhibitor gabexate mesilate in acute pancreatitis. Int J Pancreatol1991; 9: 75–79.
16.
HsuJTChenHChiuDF: Efficacy of gabexate mesilate on disseminated intravascular coagulation as a complication of infection developing after abdominal surgery. J Formos Med Assoc2004; 103: 678–684.
17.
LuhSPTsaiCShauWY: Protective effects of inhaled nitric oxide and gabexate mesilate in lung reperfusion injury after transplantation from non-heart-beat donors. J Heart Lung Transplant2002; 21: 251–259.
18.
HaradaNOkajimaKKushimotoS: Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation. Crit Care Med1999; 27: 1958–1964.
19.
ChenCCWangSTsaySH: Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis. Cytokine2006; 33: 95–99.
20.
ManesGArdizzoneSLombardiG: Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: A randomized, controlled, multicenter study. Gastrointest Endosc2007; 65: 982–987.
